Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 1
2002 1
2006 1
2016 1
2017 2
2018 5
2020 2
2021 3
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean muro, t (240 results)?
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators. Tougeron D, et al. JAMA Oncol. 2024 Jun 1;10(6):709-717. doi: 10.1001/jamaoncol.2024.0207. JAMA Oncol. 2024. PMID: 38573643 Free PMC article. Clinical Trial.
Photo quiz. Orf.
Muron T, Biron F, Peyramond D. Muron T, et al. Clin Infect Dis. 1994 Aug;19(2):257, 349. Clin Infect Dis. 1994. PMID: 7986896 No abstract available.
Adjuvant chemotherapy for completely resected IIA-IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice.
Désage AL, Tissot C, Bayle-Bleuez S, Muron T, Deygas N, Grangeon-Vincent V, Monange B, Torche F, Vercherin P, Kaczmarek D, Tiffet O, Forest F, Vergnon JM, Bouleftour W, Fournel P. Désage AL, et al. Among authors: muron t. Transl Lung Cancer Res. 2022 Dec;11(12):2418-2437. doi: 10.21037/tlcr-22-345. Transl Lung Cancer Res. 2022. PMID: 36636405 Free PMC article.
Local treatment in the setting of de novo metastatic rectal cancer: reappraisal of prognostic factors.
Vial N, Langrand-Escure J, Diao P, Garcia MA, Jmour O, Ben Mrad M, Guy JB, Abid W, Sotton S, Espenel S, Guillaume E, Rehailia-Blanchard A, Pigné G, Trone JC, Rancoule C, Kaczmarek D, Muron T, Le Roy B, Phelip JM, Vallard A, Magné N. Vial N, et al. Among authors: muron t. Swiss Med Wkly. 2021 Dec 15;151:w30034. doi: 10.4414/smw.2021.w30034. eCollection 2021 Dec 6. Swiss Med Wkly. 2021. PMID: 34964579 Free article.
Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker.
Vallard A, Garcia MA, Diao P, Espenel S, de Laroche G, Guy JB, Mrad MB, Rancoule C, Kaczmarek D, Muron T, Pigné G, Porcheron J, Peoc'h M, Phelip JM, Langrand-Escure J, Magné N. Vallard A, et al. Among authors: muron t. Oncotarget. 2018 Apr 27;9(32):22368-22382. doi: 10.18632/oncotarget.25023. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854285 Free PMC article.
Development and validation of the FIP-Score for the screening of FIP1L1::PDGFRA-associated hypereosinophilic syndrome.
Stammler R, Vallée A, Rohmer J, Grardel N, Abisror N, Chahla WA, Ackermann F, Baudet A, Belfeki N, Ben Abdelali R, Bidet A, Bladé JS, Bleuse S, Bonnotte B, Bouderbala MA, Cayuela JM, Chebrek S, Dion J, Dossier A, Duployez N, Faguer S, Flandrin-Gresta P, Galicier L, Godon C, Grall M, Jachiet V, Jouvray M, Latu I, Ledoult E, Lengline E, Leurs A, Lhermitte L, Lifermann F, Limal N, Lioger B, Lugosi M, Machelart I, Martin M, Martis N, Mauvieux L, Melboucy-Belkhir S, Mohr C, Moulis G, Mozicconacci MJ, Naguib D, Néel A, Nicolini FE, Outh R, Panel K, Preudhomme C, Puyade M, Quemeneur T, Moranne VQ, Rey J, Rousselot P, Schleinitz N, Slama B, Staumont-Salle D, Taillé C, Terriou L, Tréfond L, Viallard JF, Kahn JE, Lefèvre G, Groh M; COHESion, CEREO and GBMHM groups. Stammler R, et al. J Allergy Clin Immunol Pract. 2025 Sep 22:S2213-2198(25)00903-1. doi: 10.1016/j.jaip.2025.09.009. Online ahead of print. J Allergy Clin Immunol Pract. 2025. PMID: 40992688
20 results